Search Results 1011-1020 of 17123 for Antagonist

  1. Genomic and Proteomic Analyses of Aggressive Tumors - Mayo Clinic

    About this study. The purpose of this study is to use genomic and proteomic analyses to identify possible diagnostic markers and potential drugs for ...

  2. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. EDIT&RES Trial - Mayo Clinic

    The purpose of this study is to investigate the association between changes in adenosine-to-inosine (A-to-I) RNA editing and changes in depression severity, as ...

  5. Peripheral neuropathy - Doctors and departments - Mayo Clinic

    Learn what may cause the prickling, tingling or numb sensations of nerve damage and how to prevent and treat this painful disorder.

  6. Oxycodone and naloxone (oral route) - Side effects & dosage - Mayo Clinic

    Oxycodone belongs to the group of medicines called opioid analgesics (pain medicines). It acts on the central nervous system (CNS) to relieve pain. Naloxone is ...

  7. Anaphylaxis - Doctors and departments - Mayo Clinic

    Anaphylaxis, a severe allergic reaction, is an emergency. Learn who's at risk, what to watch for and what to do when it occurs.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  10. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16) - Mayo Clinic

    Received any approved PAH-specific therapies (i.e., endothelin receptor antagonists, prostacyclin analogs, phosphodiesterase-5 inhibitors, soluble guanylate ...